SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-21-021773
Filing Date
2021-11-04
Accepted
2021-11-04 16:12:36
Documents
45
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nltx-20210930.htm   iXBRL 10-Q 1138263
2 EX-31.1 exhibit3112021q3.htm EX-31.1 9505
3 EX-31.2 exhibit3122021q3.htm EX-31.2 9568
4 EX-32.1 exhibit3212021q3.htm EX-32.1 6872
  Complete submission text file 0001628280-21-021773.txt   3941148

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nltx-20210930.xsd EX-101.SCH 23455
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nltx-20210930_cal.xml EX-101.CAL 30727
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nltx-20210930_def.xml EX-101.DEF 105056
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nltx-20210930_lab.xml EX-101.LAB 365036
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nltx-20210930_pre.xml EX-101.PRE 221318
10 EXTRACTED XBRL INSTANCE DOCUMENT nltx-20210930_htm.xml XML 482618
Mailing Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102 206-732-2133
Neoleukin Therapeutics, Inc. (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36327 | Film No.: 211380079
SIC: 2834 Pharmaceutical Preparations